Anteris Technologies Global Corp. (NASDAQ:AVR – Get Free Report) major shareholder L1 Capital Pty Ltd sold 558,633 shares of the business’s stock in a transaction that occurred on Thursday, July 30th. The stock was sold at an average price of $8.20, for a total transaction of $4,580,790.60. Following the sale, the insider directly owned 6,633,314 shares in the company, valued at approximately $54,393,174.80. This represents a 7.77% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.
L1 Capital Pty Ltd also recently made the following trade(s):
- On Monday, July 27th, L1 Capital Pty Ltd sold 232,817 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.19, for a total transaction of $1,906,771.23.
- On Tuesday, July 28th, L1 Capital Pty Ltd sold 208,731 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.09, for a total transaction of $1,688,633.79.
- On Friday, July 24th, L1 Capital Pty Ltd sold 23,000 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.13, for a total transaction of $186,990.00.
Anteris Technologies Global Price Performance
Shares of AVR opened at $8.24 on Friday. The company’s fifty day moving average price is $9.25 and its 200-day moving average price is $7.14. Anteris Technologies Global Corp. has a 1-year low of $2.99 and a 1-year high of $11.06. The firm has a market capitalization of $802.08 million, a PE ratio of -3.70 and a beta of 1.65.
Analyst Upgrades and Downgrades
Several research firms have recently commented on AVR. Barclays upped their price objective on shares of Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a report on Friday, May 15th. Weiss Ratings restated a “sell (d-)” rating on shares of Anteris Technologies Global in a research report on Friday, May 29th. Finally, Wall Street Zen upgraded shares of Anteris Technologies Global from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Four investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $16.00.
View Our Latest Stock Analysis on Anteris Technologies Global
Institutional Investors Weigh In On Anteris Technologies Global
Several hedge funds have recently bought and sold shares of AVR. L1 Capital Pty Ltd lifted its stake in shares of Anteris Technologies Global by 143.2% in the 3rd quarter. L1 Capital Pty Ltd now owns 6,838,136 shares of the company’s stock valued at $30,772,000 after purchasing an additional 4,026,136 shares during the period. ADAR1 Capital Management LLC grew its position in Anteris Technologies Global by 205.9% during the first quarter. ADAR1 Capital Management LLC now owns 3,789,132 shares of the company’s stock valued at $21,030,000 after buying an additional 2,550,355 shares during the period. Perceptive Advisors LLC grew its position in Anteris Technologies Global by 104.4% during the first quarter. Perceptive Advisors LLC now owns 3,425,476 shares of the company’s stock valued at $19,011,000 after buying an additional 1,750,000 shares during the period. Nantahala Capital Management LLC increased its holdings in Anteris Technologies Global by 31.9% in the fourth quarter. Nantahala Capital Management LLC now owns 2,530,910 shares of the company’s stock valued at $12,629,000 after buying an additional 612,244 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in Anteris Technologies Global by 32.7% in the third quarter. JPMorgan Chase & Co. now owns 1,417,627 shares of the company’s stock valued at $6,379,000 after buying an additional 349,299 shares in the last quarter.
About Anteris Technologies Global
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Further Reading
- Five stocks we like better than Anteris Technologies Global
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
